<?xml version="1.0" encoding="UTF-8"?>
<ref id="bib0675">
 <label>63</label>
 <element-citation publication-type="journal" id="sbref0675">
  <person-group person-group-type="author">
   <name>
    <surname>Yao</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Ye</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Zhang</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Cui</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Niu</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)</article-title>
  <source>Clin Infect Dis</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1093/cid/ciaa237</pub-id>
  <comment>pii: ciaa237</comment>
 </element-citation>
</ref>
